drugset / Trial / NCT00002047

Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure

NCT00002047

Completed Glaxo Wellcome
Treatment

Summary

To evaluate the safety, tolerance, and pharmacokinetics of Retrovir (AZT) administration in HIV-infected patients in renal failure receiving maintenance hemodialysis.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Zidovudine Small molecule